HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bevacizumab for recurrent hemangioendothelioma.

AuthorsKarolin Trautmann, Anne Bethke, Gerhard Ehninger, Gunnar Folprecht
JournalActa oncologica (Stockholm, Sweden) (Acta Oncol) Vol. 50 Issue 1 Pg. 153-4 (Jan 2011) ISSN: 1651-226X [Electronic] England
PMID20950228 (Publication Type: Case Reports, Letter)
Chemical References
  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Vascular Endothelial Growth Factor A
  • Bevacizumab
Topics
  • Angiogenesis Inhibitors (therapeutic use)
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Female
  • Fractures, Spontaneous (etiology, surgery)
  • Hemangioendothelioma, Epithelioid (drug therapy, pathology, surgery)
  • Humans
  • Laminectomy
  • Lumbar Vertebrae (pathology, surgery)
  • Magnetic Resonance Imaging
  • Neoplasm Recurrence, Local (drug therapy)
  • Spinal Fusion
  • Spinal Neoplasms (complications, drug therapy, pathology, surgery)
  • Treatment Outcome
  • Vascular Endothelial Growth Factor A (antagonists & inhibitors)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: